Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
About this item
Full title
Author / Creator
KELLERER, M , KRODER, G , TIPPMER, S , BERTI, L , KIEHN, R , MOSTHAF, L and HÄRING, H
Publisher
Alexandria, VA: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
Alexandria, VA: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
Troglitazone (CS045), a compound belonging to the thiazolidine diones, is being tested as a new oral antidiabetic agent. Evidence exists from animal studies and clinical trials with non-insulin-dependent diabetes mellitus patients that Troglitazone might reduce insulin resistance. The molecular mechanism of this effect is not understood. In this st...
Alternative Titles
Full title
Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_76354347
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_76354347
Other Identifiers
ISSN
0012-1797
E-ISSN
1939-327X
DOI
10.2337/diab.43.3.447
